These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 21725609)
1. PRL-3 promotes the proliferation of LoVo cells via the upregulation of KCNN4 channels. Lai W; Chen S; Wu H; Guan Y; Liu L; Zeng Y; Zhao H; Jiang J; Chu Z Oncol Rep; 2011 Oct; 26(4):909-17. PubMed ID: 21725609 [TBL] [Abstract][Full Text] [Related]
2. Tumor-associated macrophage-derived IL-6 and IL-8 enhance invasive activity of LoVo cells induced by PRL-3 in a KCNN4 channel-dependent manner. Xu H; Lai W; Zhang Y; Liu L; Luo X; Zeng Y; Wu H; Lan Q; Chu Z BMC Cancer; 2014 May; 14():330. PubMed ID: 24885636 [TBL] [Abstract][Full Text] [Related]
3. [Expression of phosphatase of regenerating liver-3 in gastric cancer, its relationship with prognosis, and its role in gastric cancer cell proliferation]. Cai SR; Chen CQ; Wang Z; He YL; Cui J; Wu WH; Wu H; Zhan WH Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(33):2326-30. PubMed ID: 19087692 [TBL] [Abstract][Full Text] [Related]
4. KCNN4 channels participate in the EMT induced by PRL-3 in colorectal cancer. Lai W; Liu L; Zeng Y; Wu H; Xu H; Chen S; Chu Z Med Oncol; 2013; 30(2):566. PubMed ID: 23572150 [TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis identifies translationally controlled tumor protein as a mediator of phosphatase of regenerating liver-3-promoted proliferation, migration and invasion in human colon cancer cells. Chu ZH; Liu L; Zheng CX; Lai W; Li SF; Wu H; Zeng YJ; Zhao HY; Guan YF Chin Med J (Engl); 2011 Nov; 124(22):3778-85. PubMed ID: 22340241 [TBL] [Abstract][Full Text] [Related]
6. Constitutive suppression of PRL-3 inhibits invasion and proliferation of gastric cancer cell in vitro and in vivo. Matsukawa Y; Semba S; Kato H; Koma Y; Yanagihara K; Yokozaki H Pathobiology; 2010; 77(3):155-62. PubMed ID: 20516731 [TBL] [Abstract][Full Text] [Related]
7. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients. Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246 [TBL] [Abstract][Full Text] [Related]
8. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility. Fiordalisi JJ; Keller PJ; Cox AD Cancer Res; 2006 Mar; 66(6):3153-61. PubMed ID: 16540666 [TBL] [Abstract][Full Text] [Related]
10. [Effects of phosphatase of regenerating liver cell-3 gene silence by RNA interference on the expression of matrix metalloproteinases-2,-9 in human colon cancer cells]. Fan Y; Zhang YL; Zheng S Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Sep; 11(5):477-81. PubMed ID: 18803055 [TBL] [Abstract][Full Text] [Related]
11. [Role of silencing PRL-3 expression by miRNA interference in the growth of gastric cancer]. Cai SR; Wang Z; Chen CQ; Cui J; Zhang CH; He YL; Zhan WH Zhonghua Wai Ke Za Zhi; 2008 Apr; 46(8):618-21. PubMed ID: 18844061 [TBL] [Abstract][Full Text] [Related]
12. Blockage of intermediate-conductance Ca2+-activated K+ channels inhibit human pancreatic cancer cell growth in vitro. Jäger H; Dreker T; Buck A; Giehl K; Gress T; Grissmer S Mol Pharmacol; 2004 Mar; 65(3):630-8. PubMed ID: 14978241 [TBL] [Abstract][Full Text] [Related]
13. PCBP1 suppresses the translation of metastasis-associated PRL-3 phosphatase. Wang H; Vardy LA; Tan CP; Loo JM; Guo K; Li J; Lim SG; Zhou J; Chng WJ; Ng SB; Li HX; Zeng Q Cancer Cell; 2010 Jul; 18(1):52-62. PubMed ID: 20609352 [TBL] [Abstract][Full Text] [Related]
14. ATP-sensitive potassium channels control glioma cells proliferation by regulating ERK activity. Huang L; Li B; Li W; Guo H; Zou F Carcinogenesis; 2009 May; 30(5):737-44. PubMed ID: 19176641 [TBL] [Abstract][Full Text] [Related]
15. Emodin inhibits migration and invasion of DLD-1 (PRL-3) cells via inhibition of PRL-3 phosphatase activity. Han YM; Lee SK; Jeong DG; Ryu SE; Han DC; Kim DK; Kwon BM Bioorg Med Chem Lett; 2012 Jan; 22(1):323-6. PubMed ID: 22137788 [TBL] [Abstract][Full Text] [Related]
16. Selective blockade of the intermediate-conductance Ca2+-activated K+ channel suppresses proliferation of microvascular and macrovascular endothelial cells and angiogenesis in vivo. Grgic I; Eichler I; Heinau P; Si H; Brakemeier S; Hoyer J; Köhler R Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):704-9. PubMed ID: 15662023 [TBL] [Abstract][Full Text] [Related]
17. Role of silencing phosphatase of regenerationg liver-3 expression by microRNA interference in the growth of gastric cancer. Cai SR; Wang Z; Chen CQ; Wu WH; He YL; Zhan WH; Zhang CH; Cui J; Wu H Chin Med J (Engl); 2008 Dec; 121(24):2534-8. PubMed ID: 19187591 [TBL] [Abstract][Full Text] [Related]
18. The essential role of FKBP38 in regulating phosphatase of regenerating liver 3 (PRL-3) protein stability. Choi MS; Min SH; Jung H; Lee JD; Lee TH; Lee HK; Yoo OJ Biochem Biophys Res Commun; 2011 Mar; 406(2):305-9. PubMed ID: 21320469 [TBL] [Abstract][Full Text] [Related]
19. Blockage of intermediate-conductance-Ca(2+) -activated K(+) channels inhibits progression of human endometrial cancer. Wang ZH; Shen B; Yao HL; Jia YC; Ren J; Feng YJ; Wang YZ Oncogene; 2007 Aug; 26(35):5107-14. PubMed ID: 17310992 [TBL] [Abstract][Full Text] [Related]
20. High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases. Kato H; Semba S; Miskad UA; Seo Y; Kasuga M; Yokozaki H Clin Cancer Res; 2004 Nov; 10(21):7318-28. PubMed ID: 15534108 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]